(Q66401562)
Statements
A Phase 1 Open-Label, Parallel-Group, Adaptive, Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of GS-9674 in Subjects With Normal and Impaired Hepatic Function (English)
0 references
13 July 2016
0 references
16 October 2018
0 references
57
0 references
18 year
0 references